Should I buy or sell Dynatronics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DYNT, but not buy additional shares or sell existing shares. View DYNT analyst ratings or view top-rated stocks .

What is Dynatronics' stock price target for 2024?

1 equities research analysts have issued 12 month target prices for Dynatronics' shares. Their DYNT share price targets range from $3.80 to $3.80. On average, they anticipate the company's stock price to reach $3.80 in the next twelve months. This suggests a possible upside of 583.1% from the stock's current price. View analysts price targets for DYNT or view top-rated stocks among Wall Street analysts .

How have DYNT shares performed in 2024?

Dynatronics' stock was trading at $0.5850 at the beginning of 2024. Since then, DYNT shares have decreased by 4.9% and is now trading at $0.5563. View the best growth stocks for 2024 here .

Are investors shorting Dynatronics?

Dynatronics saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 16,900 shares, a decrease of 14.6% from the March 15th total of 19,800 shares. Based on an average trading volume of 18,800 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.6% of the shares of the stock are sold short. View Dynatronics' Short Interest .

When is Dynatronics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our DYNT earnings forecast .

How were Dynatronics' earnings last quarter?

Dynatronics Co. (NASDAQ:DYNT) issued its quarterly earnings results on Wednesday, February, 7th. The medical equipment provider reported ($0.27) EPS for the quarter. The medical equipment provider earned $8.15 million during the quarter. Dynatronics had a negative net margin of 14.13% and a negative trailing twelve-month return on equity of 54.88%.

When did Dynatronics' stock split?

Dynatronics's stock reverse split before market open on Tuesday, January 31st 2023. The 1-5 reverse split was announced on Tuesday, January 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What other stocks do shareholders of Dynatronics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dynatronics investors own include Biocept (BIOC) , Nuwellis (CHFS) , Heat Biologics (HTBX) , Bionano Genomics (BNGO) , iBio (IBIO) , Alto Ingredients (PEIX) , Sorrento Therapeutics (SRNE) , Palatin Technologies (PTN) and Electrameccanica Vehicles (SOLO) .

How do I buy shares of Dynatronics?

Shares of DYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:DYNT

Dynatronics (DYNT) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free DYNT Stock Alerts

$0.56

-0.03 (-5.12%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.47
▼
$0.65
50-Day Range: $0.37
▼
$0.59
52-Week Range: $0.37
▼
$1.62

Volume: 781,634 shs
Average Volume: 388,602 shs
Market Capitalization: $2.71 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.80

Get Dynatronics alerts:

Dynatronics MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 583.1% Upside
$3.80 Price Target
Short Interest: Healthy
0.57% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.44
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.85 out of 5 stars

3.0

Analyst's Opinion

Consensus Rating
Dynatronics has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Dynatronics has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.57% of the float of Dynatronics has been sold short.
Short Interest Ratio / Days to Cover
Dynatronics has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Dynatronics has recently decreased by 14.65%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Dynatronics does not currently pay a dividend.
Dividend Growth
Dynatronics does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DYNT.

2.5

News and Social Media Coverage

News Sentiment
Dynatronics has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Dynatronics this week, compared to 0 articles on an average week.
MarketBeat Follows
1 people have added Dynatronics to their MarketBeat watchlist in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Dynatronics insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 9.10% of the stock of Dynatronics is held by insiders.
Percentage Held by Institutions
Only 4.18% of the stock of Dynatronics is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Dynatronics is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Dynatronics is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Dynatronics has a P/B Ratio of 0.25. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Dynatronics Stock (NASDAQ:DYNT)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

DYNT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DYNT Stock News Headlines

April 17, 2024 | msn.com

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.17%

April 16, 2024 | markets.businessinsider.com

Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

April 18, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

April 16, 2024 | investorplace.com

Why Is Dynatronics (DYNT) Stock Up 93% Today?

April 16, 2024 | americanbankingnews.com

Dynatronics (NASDAQ:DYNT) Stock Passes Below Two Hundred Day Moving Average of $0.54

April 16, 2024 | americanbankingnews.com

Dynatronics (NASDAQ:DYNT) Receives New Coverage from Analysts at StockNews.com

April 8, 2024 | americanbankingnews.com

StockNews.com Begins Coverage on Dynatronics (NASDAQ:DYNT)

March 27, 2024 | money.usnews.com

Dynatronics Corp.

April 18, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

February 27, 2024 | markets.businessinsider.com

What Wall Street expects from Silk Road Medical's earnings

February 9, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Petmed Express (PETS), Dynatronics (DYNT) and Silk Road Medical (SILK)

February 9, 2024 | finance.yahoo.com

Dynatronics Corporation (NASDAQ:DYNT) Q2 2024 Earnings Call Transcript

February 8, 2024 | finanznachrichten.de

Dynatronics Corp.: Dynatronics Corporation Reports Second Quarter Fiscal Year 2024 Financial Results

February 8, 2024 | msn.com

Dynatronics GAAP EPS of -$0.27 misses by $0.03, revenue of $8.2M beats by $0.4M

February 8, 2024 | finance.yahoo.com

Dynatronics Corporation Reports Second Quarter Fiscal Year 2024 Financial Results

February 7, 2024 | markets.businessinsider.com

Dynatronics earnings preview: what Wall Street is expecting

January 25, 2024 | finanznachrichten.de

Dynatronics Corp.: Dynatronics Corporation Schedules Conference Call to Report Results for Second Quarter Fiscal Year 2024

January 25, 2024 | finance.yahoo.com

Dynatronics Corporation Schedules Conference Call to Report Results for Second Quarter Fiscal Year 2024

January 16, 2024 | msn.com

Implanet reports Q4 revenue decline of 20% Y/Y

January 15, 2024 | finance.yahoo.com

Dynatronics Corporation Announces Andrew Hulett as New Board Member

January 10, 2024 | msn.com

Catheter Precision reports prelim Q4,FY results

January 8, 2024 | businesswire.com

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

November 11, 2023 | finance.yahoo.com

Dynatronics Corporation (NASDAQ:DYNT) Q1 2024 Earnings Call Transcript

November 9, 2023 | benzinga.com

Dynatronics Stock (NASDAQ:DYNT) Earnings Dates and Earning Calls

November 9, 2023 | finanznachrichten.de

Dynatronics Corp.: Dynatronics Corporation Reports First Quarter Fiscal Year 2024 Financial Results

November 9, 2023 | finance.yahoo.com

Dynatronics Corporation Reports First Quarter Fiscal Year 2024 Financial Results

November 8, 2023 | markets.businessinsider.com

Here's what to expect from Dynatronics's earnings

See More Headlines

Receive DYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dynatronics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/07/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:DYNT
CUSIP: N/A
CIK: 720875
Web: www.dynatronics.com
Phone: (801) 568-7000
Fax: 801-568-7711
Employees: 154
Year Founded: 1979

Price Target and Rating

Average Stock Price Target: $3.80
High Stock Price Target: $3.80
Low Stock Price Target: $3.80
Potential Upside/Downside: +574.0%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.38)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,970,000.00
Net Margins: -14.13%
Pretax Margin: -14.10%
Return on Equity: -54.88%
Return on Assets: -16.14%

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 1.41
Quick Ratio: 0.67

Sales & Book Value

Annual Sales: $40.61 million
Price / Sales: 0.07
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.19 per share
Price / Book: 0.26

Miscellaneous

Outstanding Shares: 4,880,000
Free Float: 4,438,000
Market Cap: $2.75 million
Optionable: Not Optionable
Beta: 0.45

Social Links

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Brian D. Baker (Age 57)
CEO, President & Director
Comp: $273k
Mr. Gabe Ellwein
Chief Financial Officer
Mr. Mike Withers
Chief Information Officer

Key Competitors

View All Competitors

DYNT Stock Analysis - Frequently Asked Questions

Should I buy or sell Dynatronics stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DYNT, but not buy additional shares or sell existing shares.
View DYNT analyst ratings or view top-rated stocks.
What is Dynatronics' stock price target for 2024?: 1 equities research analysts have issued 12 month target prices for Dynatronics' shares. Their DYNT share price targets range from $3.80 to $3.80. On average, they anticipate the company's stock price to reach $3.80 in the next twelve months. This suggests a possible upside of 583.1% from the stock's current price.
View analysts price targets for DYNT or view top-rated stocks among Wall Street analysts.
How have DYNT shares performed in 2024?: Dynatronics' stock was trading at $0.5850 at the beginning of 2024. Since then, DYNT shares have decreased by 4.9% and is now trading at $0.5563.
View the best growth stocks for 2024 here.
Are investors shorting Dynatronics?: Dynatronics saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 16,900 shares, a decrease of 14.6% from the March 15th total of 19,800 shares. Based on an average trading volume of 18,800 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.6% of the shares of the stock are sold short.
View Dynatronics' Short Interest.
When is Dynatronics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our DYNT earnings forecast.

How were Dynatronics' earnings last quarter?: Dynatronics Co. (NASDAQ:DYNT) issued its quarterly earnings results on Wednesday, February, 7th. The medical equipment provider reported ($0.27) EPS for the quarter. The medical equipment provider earned $8.15 million during the quarter. Dynatronics had a negative net margin of 14.13% and a negative trailing twelve-month return on equity of 54.88%.
When did Dynatronics' stock split?: Dynatronics's stock reverse split before market open on Tuesday, January 31st 2023. The 1-5 reverse split was announced on Tuesday, January 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.
What other stocks do shareholders of Dynatronics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Dynatronics investors own include Biocept (BIOC), Nuwellis (CHFS), Heat Biologics (HTBX), Bionano Genomics (BNGO), iBio (IBIO), Alto Ingredients (PEIX), Sorrento Therapeutics (SRNE), Palatin Technologies (PTN) and Electrameccanica Vehicles (SOLO).
How do I buy shares of Dynatronics?: Shares of DYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DYNT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial